Satoris, Inc. and RayBiotech, Inc. will cooperate to develop and commercialize an Alzheimer’s blood test to detect Satoris proprietary plasma biomarkers using RayBiotech’s quantitative antibody array platform. Redwood City, Calif. and Norcross, Ga., (PRWEB) April 16, 2009 — Satoris, Inc., a molecular diagnostics company focused on developing blood-based tests for Alzheimer’s disease, and RayBiotech, Inc., […]
MicroRNA-based Molecular Diagnostics to Mark Prometheus’ Entry into Oncology Market; Rosetta to Receive Milestones and Research and Development Funding plus Future Royalties SAN DIEGO, PHILADELPHIA and REHOVOT, Israel, April 13 — Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Rosetta Genomics Ltd. (NASDAQ: ROSG) , an innovative molecular diagnostic company, today announced the […]
HUBBARD, Ohio, April 13 — NanoLogix, Inc. (OTC: NNLX) a biotechnology company, is pleased to provide the following information: An independent study has found that NanoLogix’s BNP(TM) Ultra-Fast Identification Technology allows the viewing of anthrax cultures four times faster than conventional methods. The study, by one of the foremost bio-defense and biomedical research centers in […]
– Transaction Brings Growth Opportunities in Transplant Diagnostics, Genetic Testing and Pharmaceutical Services, Accelerates European Expansion Strategy – SAN DIEGO, April 8 — Gen-Probe (Nasdaq: GPRO) announced today that the Company has completed its acquisition of Tepnel Life Sciences, plc, a rapidly growing molecular diagnostics and pharmaceutical services company based in the United Kingdom, for […]
Laboratory Already Offers Hypertrophic Cardiomyopathy (HCM) NextGen Testing ELMWOOD PARK, N.J.–BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today that it is now offering next generation sequencing testing for Dilated Cardiomyopathy (DCM) conditions through its GeneDx laboratory. GeneDx is the first commercial laboratory in the country, possibly the world, to offer clinical testing based on next generation […]
06-Apr-2009 – LGC announces plans to develop new applications for the Ibis T5000 Biosensor System in Europe LGC, the international science-based service company, has concluded an agreement with Abbott, a global healthcare company, to be the first diagnostics service provider in Europe to license the Ibis T5000 Biosensor System, for use in the rapid identification […]
Agreement Covers the Traditional Networks Which Includes PPO and Indemnity Products NEW YORK–Enzo Biochem, Inc. (NYSE:ENZ), a biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications and laboratory services, today announced that its subsidiary, Enzo Clinical Labs, Inc., has been selected as a regional provider of medical […]
Beijing, China. 2 April 2009. CapitalBio Corporation, China’s leading developer of microarray diagnostic products and total analysis solutions announced the certification of three products for diagnostic tuberculosis testing with the European CE mark. “The certification of the TB test microarrays with European CE marks represents a major step forward in our efforts to bring better […]
PASADENA, Calif.–Osmetech plc (‘Osmetech’) (LSE: OMH – News), the international molecular diagnostics business, announces that it has signed a five-year distribution agreement with Fisher HealthCare, a part of Thermo Fisher Scientific, whereby Fisher HealthCare will distribute Osmetech’s eSensor XT-8 instrument platform and molecular diagnostic tests and consumables in the U.S. James White, Chief Executive, Osmetech […]
NEWTON, Mass. & ORANGE COUNTY, Calif.–Clinical Data, Inc. (NASDAQ: CLDA) and Beckman Coulter, Inc. (NYSE: BEC) announced today that the companies have signed a definitive agreement for Beckman Coulter to acquire Clinical Data’s Cogenics division, a global leader in outsourced genomics services, for approximately $17.0 million. The sale will complete a key element of Clinical […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
